In one of the largest studies of angiogenetic markers for the assessment of women with suspected preterm preeclampsia to date, we have confirmed that in a real-world setting, low and very low PlGF categories accurately identified women with a phenotype of more severe preeclampsia. The gene discussed is PGF; the disease is preeclampsia.